0 followers
Journey Colab is pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. They plan to build a portfolio of plant-identical compounds. Their first compound in development is mescaline.
Bristol-Myers Squibb
207 followers
Syneos Health
23 followers
Organon
17 followers
NYU Langone Health
16 followers
Parexel
9 followers
Apellis Pharmaceuticals
9 followers
West Pharmaceutical Services
7 followers
Acadia Pharmaceuticals
3 followers
AbbVie
201 followers
Cambrex
3 followers
Precision Medicine Group
3 followers
Explore companies